On This Page

Traveler Summary

Key Points

  • Adenovirus infection occurs worldwide and is acquired primarily via direct contact with infected objects, inhalation of infected aerosolized respiratory droplets, and the fecal-oral route.
  • Risk is increased for children and military recruits living in crowded conditions.
  • Symptoms are usually mild and include cough, sore throat, pink eye, or fever.
  • Consequences of infection rarely occur but can include brain inflammation, severe pneumonia, and death.
  • Prevention includes observing good respiratory hygiene measures (cough and sneeze etiquette) and frequent, thorough handwashing.
  • Adenovirus vaccine (live) is routinely given to military recruits as 1 dose during initial training but is not approved for routine use or for travel.
  • Vaccine side effects are usually mild and include nasal congestion, cough, headache, abdominal pain, vomiting, and diarrhea.
  • Duration of vaccine protection is unknown; no booster dose is recommended.

Introduction

Adenovirus infections occur in infants and children worldwide and are the most common cause of respiratory tract infections. Transmission is primarily via direct contact with infected objects or inhalation of infected aerosolized droplets (e.g., from coughs or sneezes).

Risk Areas

Adenoviruses exist worldwide throughout the year; however, outbreaks of adenovirus-associated respiratory disease occur most commonly in the late winter, spring, and early summer.

Transmission

Adenoviruses are predominately transmitted via direct contact (e.g., touching infected objects and then touching the eyes), inhalation of infected aerosolized droplets (e.g., from coughs or sneezes), and the fecal-oral route; transmission from the ingestion of contaminated water occasionally occurs.

Risk Factors

Risk exists for children and military recruits (due to close living and training environment), although all ages are susceptible to infection. Infants, the elderly, and persons with underlying medical conditions are at increased risk for severe illness. On aircraft, a risk exists (although very low) of infection for persons sitting within a 2-seat range (in back, front, and beside) of an infectious traveler.

Symptoms

Symptoms most commonly appear 2 to 14 days following exposure and include runny nose, nasal congestion, sore throat, cough, fever, or diarrhea.

Consequences of Infection

Serious illness rarely occurs, but complications can include brain, stomach, or bladder inflammation, severe pneumonia, and death (higher risk in transplant patients).

Need for Medical Assistance

Travelers who develop serious symptoms of adenovirus infection should seek immediate medical attention. Antiviral drugs are generally ineffective against adenovirus infections.

Prevention

Nonvaccine

Observe good respiratory hygiene measures (cough and sneeze etiquette) and frequent, thorough handwashing, especially after using the bathroom, changing diapers, and before preparing or eating food.

Vaccine

Adenovirus vaccine (live) is given routinely to military recruits 17 to 50 years old but is not approved for routine use or travel.

Live viruses are shed in the stool for up to 28 days after vaccination. Therefore, handwashing is especially important for those who will be in close contact with children younger than 7 years, pregnant women, or persons with a weakened immune system.

Side Effects

The most common vaccine side effects of adenovirus vaccine are mild and include headache, muscle aches, nasal congestion, nausea, abdominal pain, diarrhea, and vomiting, occurring within 2 weeks after vaccination. Serious side effects are rare but can include blood in the urine or stool, stomach or intestinal inflammation, and pneumonia within 6 months after vaccination.

Persons with underlying medical conditions or who have concerns about the vaccine should speak to their health care provider before vaccine administration.

Timing

Adenovirus vaccine is given in 1 dose (2 tablets). The tablets should be swallowed whole and not chewed or crushed.

Duration of vaccine protection following a single dose as above is unknown. A booster dose is not recommended.